1361031-93-7

Upstream product

• 13397-03-0 C₃₂H₃₁NO₄*ClH 
• 1361089-32-8 C₃₂H₃₃NO₄ 
• 22231-61-4 2-[4-(benzyloxy)-3-methoxyphenyl]ethylamine 
• 29973-91-9 4-benzyloxy-3-methoxyphenylacetic acid 
• 13255-23-7 (4-benzyloxy-3-methoxy-phenyl)-acetic acid-(4-benzyloxy-3-methoxy-phenethylamide) 
• 54313-35-8 2-(4-(benzyloxy)-3-methoxyphenyl)acetyl chloride 

Downstream Products

• 1361031-94-8 C₃₃H₃₃NO₄*ClH 

Relevant academic research and scientific papers

First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)-and (-)-govadine

There is a pressing need to find and develop new antipsychotic agents for the treatment of schizophrenia. Current drugs primarily target dopamine D2receptors and are only effective in the treatment of the positive symptoms of this indication. The tetrahyd